Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Nov;22(5):499–506. doi: 10.1111/j.1365-2125.1986.tb02927.x

The plasma protein binding of basic drugs.

P A Routledge
PMCID: PMC1401182  PMID: 3790398

Abstract

The plasma protein binding of basic drugs appears to vary more than was at first assumed and is related to the marked intra-and interindividual differences in one of the chief binding proteins, AAG. Changes in AAG concentrations will result in alterations in the distribution and metabolism of basic drugs which will complicate the interpretation of the relationship between total drug concentration and drug efficacy or toxicity. For some drugs, e.g. lignocaine, direct measurement of free concentrations may improve their clinical use but rapid and reliable techniques are as yet not readily available.

Full text

PDF
504

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachmann G. W., Weiss M. E., Rapp W. Differenzierte quantitative Serumeiweissbestimmungen im Ablauf des Herzinfaktes. Schweiz Med Wochenschr. 1968 Nov 16;98(46):1825–1829. [PubMed] [Google Scholar]
  2. Barchowsky A., Shand D. G., Stargel W. W., Wagner G. S., Routledge P. A. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction. Br J Clin Pharmacol. 1982 Mar;13(3):411–415. doi: 10.1111/j.1365-2125.1982.tb01394.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barre J., Houin G., Rosenbaum J., Zini R., Dhumeaux D., Tillement J. P. Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding. Br J Clin Pharmacol. 1984 Oct;18(4):652–653. doi: 10.1111/j.1365-2125.1984.tb02525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baumann P., Tinguely D., Schöpf J. Increase of alpha 1-acid glycoprotein after treatment with amitriptyline. Br J Clin Pharmacol. 1982 Jul;14(1):102–103. doi: 10.1111/j.1365-2125.1982.tb04942.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Belpaire F. M., Bogaert M. G., Rosseneu M. Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum. Eur J Clin Pharmacol. 1982;22(3):253–256. doi: 10.1007/BF00545224. [DOI] [PubMed] [Google Scholar]
  6. Benedek I. H., Fiske W. D., 3rd, Griffen W. O., Bell R. M., Blouin R. A., McNamara P. J. Serum alpha 1-acid glycoprotein and the binding of drugs in obesity. Br J Clin Pharmacol. 1983 Dec;16(6):751–754. doi: 10.1111/j.1365-2125.1983.tb02258.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blain P. G., Mucklow J. C., Rawlins M. D., Roberts D. F., Routledge P. A., Shand D. G. Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health. Br J Clin Pharmacol. 1985 Nov;20(5):500–502. doi: 10.1111/j.1365-2125.1985.tb05107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Borgå O., Piafsky K. M., Nilsen O. G. Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):539–544. [PubMed] [Google Scholar]
  9. Cotham R. H., Shand D. Spuriously low plasma propranolol concentrations resulting from blood collection methods. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):535–538. doi: 10.1002/cpt1975185part1535. [DOI] [PubMed] [Google Scholar]
  10. Davis D., Grossman S. H., Kitchell B. B., Shand D. G., Routledge P. A. The effects of age and smoking on the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol. 1985 Feb;19(2):261–265. doi: 10.1111/j.1365-2125.1985.tb02641.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Denson D. D., Coyle D. E., Thompson G. A., Santos D., Turner P. A., Myers J. A., Knapp R. Bupivacaine protein binding in the term parturient: effects of lactic acidosis. Clin Pharmacol Ther. 1984 May;35(5):702–709. doi: 10.1038/clpt.1984.98. [DOI] [PubMed] [Google Scholar]
  12. Edwards D. J., Lalka D., Cerra F., Slaughter R. L. Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther. 1982 Jan;31(1):62–67. doi: 10.1038/clpt.1982.10. [DOI] [PubMed] [Google Scholar]
  13. Ganguly M., Westphal U. Steroid-protein interactions. XVII. Influence of solvent environment on interaction between human alpha 1-acid glycoprotein and progesterone. J Biol Chem. 1968 Dec 10;243(23):6130–6139. [PubMed] [Google Scholar]
  14. George S., McBurney A., Ward J. The protein binding of timegadine determined by equilibrium dialysis. Br J Clin Pharmacol. 1984 Nov;18(5):785–790. doi: 10.1111/j.1365-2125.1984.tb02543.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Giles H. G., Corrigall W. A., Khouw V., Sellers E. M. Plasma protein binding of phencyclidine. Clin Pharmacol Ther. 1982 Jan;31(1):77–82. doi: 10.1038/clpt.1982.12. [DOI] [PubMed] [Google Scholar]
  16. Grossman S. H., Davis D., Kitchell B. B., Shand D. G., Routledge P. A. Diazepam and lidocaine plasma protein binding in renal disease. Clin Pharmacol Ther. 1982 Mar;31(3):350–357. doi: 10.1038/clpt.1982.45. [DOI] [PubMed] [Google Scholar]
  17. Hammill S. C., Shand D. G., Routledge P. A., Hindman M. C., Baker J. T., Pritchett E. L. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics. Circulation. 1982 Feb;65(2):369–375. doi: 10.1161/01.cir.65.2.369. [DOI] [PubMed] [Google Scholar]
  18. Jackson P. R., Tucker G. T., Woods H. F. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin. Clin Pharmacol Ther. 1982 Sep;32(3):295–302. doi: 10.1038/clpt.1982.163. [DOI] [PubMed] [Google Scholar]
  19. Kristensen C. B. Imipramine serum protein binding in healthy subjects. Clin Pharmacol Ther. 1983 Nov;34(5):689–694. doi: 10.1038/clpt.1983.233. [DOI] [PubMed] [Google Scholar]
  20. Kroboth P. D., Smith R. B., Sorkin M. I., Silver M. R., Rault R., Garry M., Juhl R. P. Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentration. Clin Pharmacol Ther. 1984 Sep;36(3):379–383. doi: 10.1038/clpt.1984.191. [DOI] [PubMed] [Google Scholar]
  21. Leopold D., Webb D., Buss D. C., Fifield R. A., Smith A. P., Routledge P. A. The ex vivo plasma protein binding of theophylline in renal disease. Br J Clin Pharmacol. 1985 Jun;19(6):823–825. doi: 10.1111/j.1365-2125.1985.tb02720.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lima J. J., Boudoulas H., Blanford M. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics. J Pharmacol Exp Ther. 1981 Dec;219(3):741–747. [PubMed] [Google Scholar]
  23. Martyn J. A., Abernethy D. R., Greenblatt D. J. Plasma protein binding of drugs after severe burn injury. Clin Pharmacol Ther. 1984 Apr;35(4):535–539. doi: 10.1038/clpt.1984.73. [DOI] [PubMed] [Google Scholar]
  24. McDevitt D. G., Frisk-Holmberg M., Hollifield J. W., Shand D. G. Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther. 1976 Aug;20(2):152–157. doi: 10.1002/cpt1976202152. [DOI] [PubMed] [Google Scholar]
  25. Milsap R. L., Jusko W. J. Binding of prednisolone to alpha 1-acid glycoprotein. J Steroid Biochem. 1983 Feb;18(2):191–194. doi: 10.1016/0022-4731(83)90087-0. [DOI] [PubMed] [Google Scholar]
  26. Müller W. E., Stillbauer A. E. Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid). Naunyn Schmiedebergs Arch Pharmacol. 1983 Mar;322(2):170–173. doi: 10.1007/BF00512392. [DOI] [PubMed] [Google Scholar]
  27. Nation R. L. Meperidine binding in maternal and fetal plasma. Clin Pharmacol Ther. 1981 Apr;29(4):472–479. doi: 10.1038/clpt.1981.65. [DOI] [PubMed] [Google Scholar]
  28. Nilsen O. G., Leren P., Aakesson I., Jacobsen S. Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol. 1978 Mar 15;27(6):871–876. doi: 10.1016/0006-2952(78)90411-2. [DOI] [PubMed] [Google Scholar]
  29. Ochs H. R., Carstens G., Greenblatt D. J. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med. 1980 Aug 14;303(7):373–377. doi: 10.1056/NEJM198008143030705. [DOI] [PubMed] [Google Scholar]
  30. Piafsky K. M., Borga O. Inhibitor of drug-protein binding in "Vacutainers". Lancet. 1976 Oct 30;2(7992):963–964. doi: 10.1016/s0140-6736(76)90927-2. [DOI] [PubMed] [Google Scholar]
  31. Piafsky K. M., Borgá O., Odar-Cederlöf I., Johansson C., Sjöqvist F. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med. 1978 Dec 28;299(26):1435–1439. doi: 10.1056/NEJM197812282992604. [DOI] [PubMed] [Google Scholar]
  32. Piafsky K. M., Borgå O. Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):545–549. doi: 10.1002/cpt1977225part1545. [DOI] [PubMed] [Google Scholar]
  33. Pike E., Kierulf P., Skuterud B., Bredesen J. E., Lunde P. K. Drug binding in sera deficient in lipoproteins, albumin or orosomucoid. Br J Clin Pharmacol. 1983 Sep;16(3):233–239. doi: 10.1111/j.1365-2125.1983.tb02155.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pike E., Skuterud B. Plasma binding variations of amitriptyline and nortriptyline. Clin Pharmacol Ther. 1982 Aug;32(2):228–234. doi: 10.1038/clpt.1982.152. [DOI] [PubMed] [Google Scholar]
  35. Romach M. K., Piafsky K. M., Abel J. G., Khouw V., Sellers E. M. Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther. 1981 Feb;29(2):211–217. doi: 10.1038/clpt.1981.34. [DOI] [PubMed] [Google Scholar]
  36. Routledge P. A., Barchowsky A., Bjornsson T. D., Kitchell B. B., Shand D. G. Lidocaine plasma protein binding. Clin Pharmacol Ther. 1980 Mar;27(3):347–351. doi: 10.1038/clpt.1980.46. [DOI] [PubMed] [Google Scholar]
  37. Routledge P. A., Lazar J. D., Barchowsky A., Stargel W. W., Wagner G. S., Shand D. G. A free lignocaine index as a guide to unbound drug concentration. Br J Clin Pharmacol. 1985 Dec;20(6):695–698. doi: 10.1111/j.1365-2125.1985.tb05132.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Routledge P. A., Stargel W. W., Barchowsky A., Wagner G. S., Shand D. G. Control of lidocaine therapy: new perspectives. Ther Drug Monit. 1982;4(3):265–270. doi: 10.1097/00007691-198208000-00003. [DOI] [PubMed] [Google Scholar]
  39. Routledge P. A., Stargel W. W., Finn A. L., Barchowsky A., Shand D. G. Lignocaine disposition in blood in epilepsy. Br J Clin Pharmacol. 1981 Nov;12(5):663–666. doi: 10.1111/j.1365-2125.1981.tb01286.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Routledge P. A., Stargel W. W., Kitchell B. B., Barchowsky A., Shand D. G. Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol. 1981 Mar;11(3):245–250. doi: 10.1111/j.1365-2125.1981.tb00528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Routledge P. A., Stargel W. W., Wagner G. S., Shand D. G. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Ann Intern Med. 1980 Nov;93(5):701–704. doi: 10.7326/0003-4819-93-5-701. [DOI] [PubMed] [Google Scholar]
  42. Routledge P. A., Stargel W. W., Wagner G. S., Shand D. G. Increased plasma propranolol binding in myocardial infarction. Br J Clin Pharmacol. 1980 Apr;9(4):438–440. doi: 10.1111/j.1365-2125.1980.tb01077.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Song C. S., Merkatz I. R., Rifkind A. B., Gillette P. N., Kappas A. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Studies with a quantitative immunodiffusion method. Am J Obstet Gynecol. 1970 Sep 15;108(2):227–231. doi: 10.1016/0002-9378(70)90301-7. [DOI] [PubMed] [Google Scholar]
  44. Stargel W. W., Roe C. R., Routledge P. A., Shand D. G. Importance of blood-collection tubes in plasma lidocaine determinations. Clin Chem. 1979 Apr;25(4):617–619. [PubMed] [Google Scholar]
  45. Störiko K. Normal values for 23 different human plasma proteins determined by single radial immunodiffusion. Blut. 1968 Jan;16(4):200–208. doi: 10.1007/BF01631669. [DOI] [PubMed] [Google Scholar]
  46. Teirlynck O., Belpaire F. M., Andreasen F. Binding of aprindine and moxaprindine to human serum, alpha 1-acid glycoprotein and serum of healthy and diseased humans. Eur J Clin Pharmacol. 1982;21(5):427–431. doi: 10.1007/BF00542331. [DOI] [PubMed] [Google Scholar]
  47. Tiula E., Neuvonen P. J. Antiepileptic drugs and alpha 1-acid glycoprotein. N Engl J Med. 1982 Oct 28;307(18):1148–1148. doi: 10.1056/NEJM198210283071813. [DOI] [PubMed] [Google Scholar]
  48. Urien S., Albengres E., Comte A., Kiechel J. R., Tillement J. P. Plasma protein binding and erythrocyte partitioning of nicardipine in vitro. J Cardiovasc Pharmacol. 1985 Sep-Oct;7(5):891–898. doi: 10.1097/00005344-198509000-00012. [DOI] [PubMed] [Google Scholar]
  49. Urien S., Albengres E., Zini R., Tillement J. P. Evidence for binding of certain acidic drugs to alpha 1-acid glycoprotein. Biochem Pharmacol. 1982 Nov 15;31(22):3687–3689. doi: 10.1016/0006-2952(82)90597-4. [DOI] [PubMed] [Google Scholar]
  50. Webb D., Buss D. C., Fifield R., Bateman D. N., Routledge P. A. The plasma protein binding of metoclopramide in health and renal disease. Br J Clin Pharmacol. 1986 Mar;21(3):334–336. doi: 10.1111/j.1365-2125.1986.tb05201.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wilkinson G. R., Shand D. G. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975 Oct;18(4):377–390. doi: 10.1002/cpt1975184377. [DOI] [PubMed] [Google Scholar]
  52. Wood M., Wood A. J. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther. 1981 Apr;29(4):522–526. doi: 10.1038/clpt.1981.73. [DOI] [PubMed] [Google Scholar]
  53. Yost R. L., DeVane C. L. Diurnal variation of alpha 1-acid glycoprotein concentration in normal volunteers. J Pharm Sci. 1985 Jul;74(7):777–779. doi: 10.1002/jps.2600740718. [DOI] [PubMed] [Google Scholar]
  54. van der Sluijs P., Meijer D. K. Binding of drugs with a quaternary ammonium group to alpha-1 acid glycoprotein and asialo alpha-1 acid glycoprotein. J Pharmacol Exp Ther. 1985 Sep;234(3):703–707. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES